Research centre leads 3D bioprinting revolution
RMIT is a key partner in BioFab3D@AMCD, Australia’s first robotics and biomedical engineering centre embedded within a hospital. Their vision is to “eventually lead to real-time printing of 3D implants, while a patient is in surgery.”
Professor Peter Coloe, Deputy Vice Chancellor Science, Engineering and Health and Vice-President, said the collaborative partnership has enabled RMIT to remain at the forefront of the 3D bioprinting revolution.
“We want to contribute to understanding and solving the biggest challenges faced by industry and the community, so our research can make a real impact,” Coloe said.
“Working closely with industry and medical specialists, our researchers were able to develop Australia’s first 3D-printed spinal implant.
“It’s this kind of vital collaboration that BioFab3D@AMCD will support, pulling together not only the best research minds but top clinicians and industry partners, who all share the same vision of transforming the lives of patients through pioneering biomedical engineering innovations.”